Melissa Gee

Melissa Gee, Ph.D. has held various leadership roles in analytical development, science, and technology in the life sciences industry. At Seres Therapeutics, Melissa is responsible for functions crucial to the launch of the first oral microbiome FDA-approved therapeutic. Melissa previously led initiatives in COVID-19 response and research at Partners In Health. With a background in biology and molecular biology, Melissa has a proven track record in leading research and development teams in clinical diagnostics and lead discovery.